Clinical Trials at MedArk
During the past decade, MedArk conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at MedArk
According to Clinical.Site data, the most researched conditions in "MedArk" are
"Alzheimer's Disease" (2 trials). Many other conditions were trialed in "MedArk" in a lesser frequency.
Clinical Trials Intervention Types at MedArk
Most popular intervention types in "MedArk" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "PRX-03140" (2 trials), "Placebo" (2 trials) and "Donepezil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MedArk
The vast majority of trials in "MedArk" are
2 trials for "All" genders.
Clinical Trials Status at MedArk
Currently, there are NaN active trials in "MedArk".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in MedArk,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in MedArk, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".